Experiment 69614
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Phaseolus vulgaris (FABACEAE) |
| Citation | UDANI,J: HARDY,M: MADSEN,DC:. (2004). BLOCKING CARBOHYDRATE ABSORPTION AND WEIGHT LOSS: A CLINICAL TRIAL USING PHASE 2 BRAND PROPRIETARY FRACTIONATED WHITE BEAN EXTRACT.. 9(1) |
| Amount utilized | |
| Compound isolated | |
| Disease | SND A DECREASE IN TRIGLYCERIDES, ALTHOUGH STATISTICAL SIGNIFICANCE WAS NOT REACHED. AN AVERAGE OF 26.3 MG/DL, MORE THAN 3 TIMES GREATER A REDUCTION THAN OBSERVED IN THE PLACEBO GROUP (8.2 MG/DL) (P=0.07). NO ADVERSE EVENTS DURING THE STUDY WERE ATTRIBUTED TO THE STUDY MEDICATION. CLINICAL TRENDS WERE IDENTIFIED FOR WEIGHT LOSS AVERAGE OF3.79 LBS (AVERAGE OF .47 LBS PER WEEK) COMPARED WITH THE PLACEBO GROUP, WHICH LOST AN AVERAGE OF 1.65 LBS (AVERAGE OF 0.21 LB PER WEEK), RESPRESENTING A DIFFERENCE OF 129% (P=0.35). TRIGLYCERIDE LEVELS IN THE PHASE 2 GROUP WERE REDUCED OR AN IDENTICAL PLACEBO TWICE DAILY WITH MEALS. THE ACTIVE STUDY PERIOD WAS EIGHT WEEKS. 39 SUBJECTS COMPLETED THE INITIAL SCREENING PROCESS AND 27 SUBJECTS COMPLETED THE STUDY. THE RESULTS AFTER 8 WKS DEMONSTRATED THE PHASE 2 GROUP LOST AN 50 OBESE ADULTS WERE SCREENED TO PARTICIPATE IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFECTS OF TREATMENT WITH PHASE 2 VIRSUS PLACEBO ON WEIGHT LOSS. PARTICIPANTS WERE RANDOMIZED TO RECEIVE EITHER 1500 MG PHASE 2 |
| Dose amount | 3.0 GM |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | TYPE EXT NOT STATED |
| Gender | GIVEN TO BOTH SEXES |